Sanofi/GSK restart COVID-19 vaccine trials after tweaking formulation
pharmaphorum
FEBRUARY 22, 2021
Sanofi and GlaxoSmithKline are restarting clinical development of their COVID-19 vaccine, which was delayed after hitting a snag late last year. Regulators in the US and UK are reviewing data from another vaccine from Novavax. The post Sanofi/GSK restart COVID-19 vaccine trials after tweaking formulation appeared first on.
89 
Let's personalize your content